Debiopharm Innovation Fund Investors
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Invests into
Funding Status:
N/A
Industry:
Imaging
Estimated Revenue:
$4.7M.
Acquisitions Number:
NA
Number Of Exists:
6
Headquarters:
Lausanne, Vaud, Switzerland
Investor Type:
Venture Capital
Employee Number:
1-10
Investors Number:
24
Investment Stage:
Late Stage Venture, Venture
Zip:
NA
Founded Date:
2012-01-01